Abortion Providers Sue to Preserve Mifepristone Access

Senator Lankford responds to FDA limitations on reporting complications from abortions.

A group of abortion providers filed a lawsuit this week to lift federal restrictions on mifepristone, an abortion pill used during the first 10 weeks of pregnancy. Though the lawsuit names the Food and Drug Administration (FDA) as the defendant, it is seen as a response to a lawsuit filed by pro-life groups last year, which moved U.S. District Judge Matthew Kacsmaryk to suspend FDA approval of mifepristone use on April 10.

The Supreme Court placed a stay on Judge Kacsmaryk’s order while that case and oral arguments are to be heard before a three-judge panel of the Fifth Circuit Court on May 17. This suit challenges the manner in which the FDA approved the abortion drug. The pro-life physicians are also concerned over the restrictions the FDA has in place on reporting adverse health outcomes surrounding abortions.

Senator James Lankford of Oklahoma recently stated he was “shocked” by the FDA’s reporting limitations on the complications from abortion procedures. He said, “If the woman has to go to the emergency room if she has excessive bleeding, if there are other major complications, even if she is in the ER on life support for days and days and days, if she recovers from that, [the FDA says], ‘Don’t tell us about it. Only tell us if she dies.’”

As the Lord Leads, Pray with Us…

  • For wisdom for the judges of the 5th Circuit Court of Appeals as they consider the appeal of Judge Kacsmaryk’s ruling.
  • For the judges hearing the case brought by the abortion providers to be discerning in their decision.
  • For Senator Lankford as he advocates for the sanctity of life.

Sources: Reuters, LifeNews


Back to top